Frozen plasma, buffy coat, FFPE blocks and slides
Research

Reference Medicine presents findings of MammaPrint® recurrence risk stratification in early-stage breast carcinomas at SABCS 2024

Dec 11, 2024

Study investigating the correlation between high TILs and early-stage breast cancer recurrence risk using MammaPrint® and BluePrint® genomic tests.

As presented at the San Antonio Breast Cancer Symposium 2024.

  • Presented by: Zoran Gatalica, MD
  • Poster: P1-11-17, December 11, 2024, 10:00AM – 2:00 PM
Download

Subscribe for updates

No spam — just the news you want: product launches, process improvements, and discounts on our already great pricing.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Media Contact

For more information or to schedule an interview, please contact:
Jen Ringler
ReadHealthy Communications
jringler@readhealthy.net

Share this post

More research
Research
Nov 23, 2024

Chris Diehnelt, Founder and CEO at Robust Diagnostics, presents peptide microarray research at AMP 2024

Read article
Research
Nov 22, 2024

Chris Diehnelt, Founder and CEO at Robust Diagnostics, presents Streck tube research at AMP 2024

Read article
Research
Nov 14, 2024

Reference Medicine presents findings on the quality of bio-banked tissue – blood matched samples at AACR Liquid Biopsy Conference

Read article
See all
Process
Products
Pricing
Inventory

Subscribe to our newsletter

No spam — just the news you want: product launches, process improvements, and discounts on our already great pricing.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
 | 
© 2024 Reference Medicine. All rights reserved